EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 59 filers reported holding EDGEWISE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,024,519 | -25.0% | 527,839 | +1.4% | 0.00% | -33.3% |
| Q2 2023 | $4,033,894 | +19.0% | 520,502 | +2.2% | 0.00% | 0.0% |
| Q1 2023 | $3,389,420 | -25.0% | 509,062 | +0.7% | 0.00% | -25.0% |
| Q4 2022 | $4,520,806 | -7.9% | 505,683 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $4,909,000 | +102.3% | 498,861 | +63.7% | 0.00% | +100.0% |
| Q2 2022 | $2,426,000 | -18.0% | 304,713 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $2,957,000 | -36.4% | 304,881 | +0.2% | 0.00% | -33.3% |
| Q4 2021 | $4,651,000 | -4.8% | 304,379 | +3.4% | 0.00% | 0.0% |
| Q3 2021 | $4,888,000 | -22.1% | 294,412 | +0.0% | 0.00% | -25.0% |
| Q2 2021 | $6,278,000 | -30.7% | 294,310 | +5.6% | 0.00% | -42.9% |
| Q1 2021 | $9,054,000 | – | 278,577 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |